ইস্রায়েল - হিব্রু - Ministry of Health

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.25 mg/dose; formoterol fumarate dihydrate 0.01 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.

ইস্রায়েল - হিব্রু - Ministry of Health

organon pharma israel ltd., israel - betamethasone as dipropionate; gentamicin as sulfate - משחה - betamethasone as dipropionate 0.5 mg / 1 g; gentamicin as sulfate 1 mg / 1 g - topical treatment of dermatosis complicated by secondary infection caused by organisms sensitive to gentamicin

ইস্রায়েল - হিব্রু - Ministry of Health

organon pharma israel ltd., israel - betamethasone as dipropionate; clotrimazole; gentamicin (as sulfate) - קרם - clotrimazole 10 mg/g; betamethasone as dipropionate 0.5 mg/g; gentamicin (as sulfate) 1 mg/g - corticosteroids, potent, other combinations - treatment of corticosteroid-responsive dermatoses when complicated by infections caused by bacteria (sensitive to gentamicin) and fungi (sensitive to clotrimazole) or when the possibility of such infections is suspected. the cream is suitable for the use of oozing eczema.

ইস্রায়েল - হিব্রু - Ministry of Health

organon pharma israel ltd., israel - betamethasone as dipropionate; gentamicin (as sulfate) - קרם - gentamicin (as sulfate) 1 mg/g; betamethasone as dipropionate 0.5 mg/g - corticosteroids, potent, combinations with antibiotics - for the relief of the inflammatory manifestations of corticosteroid-responsive dermatoses when complicated by secondary infections caused by organisms susceptible to gentamycin.

ইস্রায়েল - হিব্রু - Ministry of Health

trima israel pharmaceutical products maabarot ltd - betamethasone as valerate; gentamicin as sulfate - משחה - betamethasone as valerate 0.1 %w/w; gentamicin as sulfate 0.1 %w/w - betamethasone - betamethasone - for local treatment of inflammatory dermatoses and allergic skin conditions complicated by infections.

ইস্রায়েল - হিব্রু - Ministry of Health

trima israel pharmaceutical products maabarot ltd - betamethasone as valerate; gentamicin as sulfate - קרם - betamethasone as valerate 0.1 %w/w; gentamicin as sulfate 0.1 %w/w - betamethasone and antibiotics - betamethasone and antibiotics - for local treatment of inflammatory dermatoses and allergic skin conditions complicated by infections.

ইস্রায়েল - হিব্রু - Ministry of Health

sanofi israel ltd - levofloxacin as hemihydrate - טבליות מצופות פילם - levofloxacin as hemihydrate 500 mg - levofloxacin - levofloxacin - in adults with infections of mild to moderate severity tavanic tablets are indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: acute sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, complicated urinary tract infections including pyelonephritis, skin and soft tissue infections.

ইস্রায়েল - হিব্রু - Ministry of Health

unipharm ltd, israel - levofloxacin hemihydrate - טבליה - levofloxacin hemihydrate 500 mg - levofloxacin - levofloxacin - in adults with infections of mild to moderate severity for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: acute sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, complicated urinary tract infections including pyelonephritis, skin and soft tissue infections.

ইস্রায়েল - হিব্রু - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - תמיסה לאינפוזיה - moxifloxacin as hydrochloride 1.6 mg/ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.

ইস্রায়েল - হিব্রু - Ministry of Health

unipharm ltd, israel - azithromycin as dihydrate - טבליות מצופות - azithromycin as dihydrate 250 mg - azithromycin - azithromycin - zeto is indicated for infections caused by susceptible organisms, in low respiratory tract infections including bronchitis and pneumonia, skin and soft tissue infections, otitis media and in upper respiratory tract infections including sinusitis and pharyngitis/tonsilitis.it is also used for the treatment of uncomplicated genital infections due to chlamydia trachomatis.